[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"fluorescein-angiography\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:fluorescein-angiography":31},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":33,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":43,"leadSponsor":45,"locationsCount":5},"100574543","fluorescein-angiography-in-patients-with-diabetes-and-chronic-kidney-disease-100574543",false,"NCT06760650","Fluorescein Angiography in Patients With Diabetes and Chronic Kidney Disease","Fluorescein-Induced Acute Kidney Injury in Patients With Diabetes and Chronic Kidney Disease","Fluo-AKI","Inclusion Criteria:\n\n* \\>18 years old with type 2 or type 1 diabetes and chronic kidney disease stage 3b to 5 (eGFR\\\u003C45 mL\u002Fmin\u002F1.73 m2)\n\nExclusion Criteria:\n\n* Patients who do not give their consent\n* Patients who are allergic to fluorescein\n* Patients who are on dialysis\n* Patients who had fever, vomiting, diarrhea or any dehydration 48 hours before the intervention\n* Patients who had a treatment modification one week before the intervention","ALL","18 Years",{"count":20,"type":21},35,"ESTIMATED","INTERVENTIONAL",[24],"NA","Our study hypothesizes that fluorescein exposure in diabetic patients with advanced chronic kidney disease results in deterioration of kidney function. It will therefore aim to evaluate the incidence of acute kidney injury induced by fluorescein in diabetic patients with CKD. The objective is to determine the incidence, severity and risk factors associated with this deterioration to improve the care of this specific population.",[27,28,29,30,31,32],"Chronic Kidney Disease Stage 4","Chronic Kidney Disease Stage 3B","Chronic Kidney Disease Stage 5","Diabetes Mellitus","Fluorescein Angiography","Acute Kidney Injury",[31,34,35,36],"Acute kidney injury","Chronic kidney disease","Diabetes","NOT_YET_RECRUITING","2025-01-03",{"date":40,"type":41},"2025-01-07","ACTUAL",{"date":40,"type":21},{"date":44,"type":21},"2025-10-10",{"name":46,"class":47},"Saint-Joseph University","OTHER"]